Showing 19,221 - 19,240 results of 41,669 for search '(( a point decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.75s Refine Results
  1. 19221

    Image_1_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.TIF by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  2. 19222

    Table_4_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.docx by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  3. 19223

    Image_2_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.TIF by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  4. 19224

    Table_3_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.docx by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  5. 19225

    Table_1_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.docx by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  6. 19226

    Table_2_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.docx by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  7. 19227

    Image_3_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.TIF by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  8. 19228

    The method presented in this paper for quickly identifying a network’s MIB using spectral clustering makes it possible to quickly measure integrated information in large brain netw... by Daniel Toker (6311834)

    Published 2019
    “…Following Watts and Strogatz [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006807#pcbi.1006807.ref053" target="_blank">53</a>], we varied <i>p</i> on a log-scale between 0.001 and 0.1; to explore the full parameter space, we also linearly varied <i>p</i> between 0.1 and 1. …”
  9. 19229
  10. 19230
  11. 19231
  12. 19232
  13. 19233
  14. 19234

    DataSheet_1_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.docx by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  15. 19235

    M-TUBE is a fabrication-free, microfluidics tubing-based bacterial electroporation device that is simple to assemble and exhibits higher electroporation efficiency than cuvettes. by Po-Hsun Huang (183737)

    Published 2022
    “…Transformation was dependent on the electric field. For M-TUBE devices, a voltage of ±2.50 kV (AC field) was applied, which results in an electric field of 8.33 kV/cm. …”
  16. 19236

    DataSheet_2_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.pdf by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  17. 19237
  18. 19238
  19. 19239

    NK-DLI<sub>IL-2 stim</sub> but not NK-DLI<sub>unstim</sub> led to a considerable disappearance of NK cells from PB. by Claudia Brehm (197437)

    Published 2011
    “…Striped bars indicate estimated patient's PB volume and peripheral NK cell count at the time point of NK-DLI infusion. <u>Left graph</u> shows a mean 5.5-fold reduction of absolute NK cell count in the PB as early as 10 min post NK-DLI<sub>IL-2 stim</sub> compared to a 1.2-fold decrease for NK-DLI<sub>unstim</sub>. …”
  20. 19240

    Fig 6 - by Annika Åstrand (6920525)

    Published 2024
    “…Results of the linear mixed models (differences in LS means <i>versus</i> 3-hour and 20°C baseline) for each marker by time point and temperature are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0301845#pone.0301845.s010" target="_blank">S10 Table</a>. …”